{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:07:08Z","timestamp":1792534028307,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clinre.2023.102248","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T17:48:31Z","timestamp":1700156911000},"page":"102248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Glutamine synthetase and hepatocellular carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Jinghua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianSheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2023.102248_bib0001","doi-asserted-by":"crossref","first-page":"2025S","DOI":"10.1093\/jn\/138.10.2025S","article-title":"Nonnutritive effects of glutamine","volume":"138","author":"Roth","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.clinre.2023.102248_bib0002","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1042\/bj0291951","article-title":"Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues","volume":"29","author":"Krebs","year":"1935","journal-title":"Biochem J"},{"key":"10.1016\/j.clinre.2023.102248_bib0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2023.102248_bib0004","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1055\/s-2007-1024611","article-title":"Amino acid metabolism, muscular fatigue and muscle wasting. Speculations on adaptations at high altitude","volume":"13","author":"Wagenmakers","year":"1992","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/138955708785132800","article-title":"Inhibitors of glutamine synthetase and their potential application in medicine","volume":"8","author":"Berlicki","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.clinre.2023.102248_bib0006","first-page":"22","article-title":"Glutamine synthetase as a therapeutic target for cancer treatment","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2023.102248_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jmb.2007.10.029","article-title":"Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design","volume":"375","author":"Krajewski","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinre.2023.102248_bib0008","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.7314\/APJCP.2015.16.11.4769","article-title":"Roles of combined glypican-3 and glutamine synthetase in differential diagnosis of hepatocellular lesions","volume":"16","author":"Wasfy","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clinre.2023.102248_bib0009","doi-asserted-by":"crossref","first-page":"983S","DOI":"10.1093\/jn\/130.4.983S","article-title":"Glutamine and glutamate metabolism across the liver sinusoid","volume":"130","author":"Watford","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.clinre.2023.102248_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0168-8278(00)80365-7","article-title":"Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma","volume":"33","author":"Osada","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5858\/arpa.2013-0645-OA","article-title":"A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions","volume":"139","author":"Swanson","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0012","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.molcel.2021.04.002","article-title":"SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells","volume":"81","author":"Tong","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.clinre.2023.102248_bib0013","doi-asserted-by":"crossref","first-page":"F701","DOI":"10.1152\/ajprenal.00030.2013","article-title":"Expression of glutamine synthetase in the mouse kidney: localization in multiple epithelial cell types and differential regulation by hypokalemia","volume":"305","author":"Verlander","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinre.2023.102248_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2023.102248_bib0015","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.18632\/oncotarget.1958","article-title":"Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells","volume":"5","author":"Brunelli","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinre.2023.102248_bib0016","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.celrep.2019.09.056","article-title":"Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism","volume":"29","author":"Bott","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.clinre.2023.102248_bib0017","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.1041200213","article-title":"Regulation of glutamine synthetase and glutaminase activities in cultured skeletal muscle cells","volume":"120","author":"Smith","year":"1984","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clinre.2023.102248_bib0018","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","article-title":"The inhibition of glutamine synthetase sensitizes human sarcoma cells to l-asparaginase","volume":"60","author":"Tardito","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinre.2023.102248_bib0019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0197-0186(02)00033-5","article-title":"Glutamine synthetase in brain: effect of ammonia","volume":"41","author":"Suarez","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.clinre.2023.102248_bib0020","doi-asserted-by":"crossref","first-page":"11949","DOI":"10.1073\/pnas.89.24.11949","article-title":"Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker","volume":"89","author":"Gunnersen","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.clinre.2023.102248_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2004.12.012","article-title":"Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia","volume":"75","author":"Bruneau","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0022","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0016-5085(94)90552-5","article-title":"Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy","volume":"107","author":"Haussinger","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2023.102248_bib0023","first-page":"195","article-title":"Pathophysiology of hepatic encephalopathy and future treatment options","volume":"84","author":"Gonzalez-Regueiro","year":"2019","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.clinre.2023.102248_bib0024","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1111\/epi.17072","article-title":"Small loci of astroglial glutamine synthetase deficiency in the postnatal brain cause epileptic seizures and impaired functional connectivity","volume":"62","author":"Farina","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinre.2023.102248_bib0025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/jnr.24267","article-title":"Astrocytes and glutamine synthetase in epileptogenesis","volume":"97","author":"Eid","year":"2019","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0026","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ncb2536","article-title":"Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy","volume":"14","author":"van der Vos","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clinre.2023.102248_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108703","article-title":"PPP1CA\/YAP\/GS\/Gln\/mTORC1 pathway activates retinal Muller cells during diabetic retinopathy","volume":"210","author":"Guo","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0028","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/carcin\/bgy033","article-title":"Ovarian cancer therapeutic potential of glutamine depletion based on GS expression","volume":"39","author":"Furusawa","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clinre.2023.102248_bib0029","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/jcbfm.2014.37","article-title":"Sonnewald U. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease","volume":"34","author":"Nilsen","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.clinre.2023.102248_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216040","article-title":"Pancreatic stellate cells exploit Wnt\/beta-catenin\/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth","volume":"555","author":"Liu","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2023.102248_bib0031","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/hep.21322","article-title":"Hepatic expression of glutamine synthetase in rats is controlled by STAT5 and TCF transcription factors","volume":"44","author":"Werth","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2023.102248_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1242059","article-title":"Glutamine metabolic reprogramming in hepatocellular carcinoma","volume":"10","author":"Ye","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clinre.2023.102248_bib0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0034","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinre.2023.102248_bib0035","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2014.00177","article-title":"Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools","volume":"5","author":"Meli","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinre.2023.102248_bib0037","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.febslet.2014.11.015","article-title":"Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels","volume":"588","author":"Palmieri","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinre.2023.102248_bib0038","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0039","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0040","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1074\/jbc.M115.709048","article-title":"Toll-like receptor 4 on macrophage promotes the development of steatohepatitis-related hepatocellular carcinoma in mice","volume":"291","author":"Miura","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2023.102248_bib0041","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajpath.2015.09.015","article-title":"Diet-Induced obesity enhances progression of hepatocellular carcinoma through tenascin-C\/Toll-like receptor 4 signaling","volume":"186","author":"Benbow","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinre.2023.102248_bib0042","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ajcp\/aqaa114","article-title":"Transcriptomic and proteomic analysis of steatohepatitic hepatocellular carcinoma reveals novel distinct biologic features","volume":"155","author":"Van Treeck","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinre.2023.102248_bib0043","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00428-015-1836-2","article-title":"\u03b2-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study","volume":"467","author":"Ando","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clinre.2023.102248_bib0044","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1038\/emm.2017.174","article-title":"Glutamine synthetase mediates sorafenib sensitivity in \u03b2-catenin-active hepatocellular carcinoma cells","volume":"50","author":"Sohn","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0046","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clinre.2023.102248_bib0047","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/hepr.13933","article-title":"Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy","volume":"53","author":"Kurebayashi","year":"2023","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0048","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2023.102248_bib0049","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.clinre.2023.102248_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","article-title":"Role of glutamine synthetase in angiogenesis beyond glutamine synthesis","volume":"561","author":"Eelen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2023.102248_bib0051","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2003014118","article-title":"Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1","volume":"118","author":"Tsai","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinre.2023.102248_bib0052","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41389-019-0129-z","article-title":"Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth","volume":"8","author":"Issaq","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.clinre.2023.102248_bib0053","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4274\/tjh.galenos.2021.2021.0054","article-title":"Leukemia cells resistant to glutamine deprivation express glutamine synthetase protein","volume":"39","author":"Yucel","year":"2022","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.clinre.2023.102248_bib0054","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/1878-0261.12877","article-title":"Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia","volume":"15","author":"Nguyen","year":"2021","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clinre.2023.102248_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104809","article-title":"Novel aspects of glutamine synthetase in ammonia homeostasis","volume":"140","author":"Zhou","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/j.clinre.2023.102248_bib0056","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ymgme.2011.02.001","article-title":"Natural course of glutamine synthetase deficiency in a 3 year old patient","volume":"103","author":"Haberle","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinre.2023.102248_bib0057","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinre.2023.102248_bib0058","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.29498","article-title":"Projections of primary liver cancer to 2030 in 30 countries worldwide","volume":"67","author":"Valery","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2023.102248_bib0059","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1258\/096914103771773320","article-title":"Screening for liver cancer: results of a randomised controlled trial in Qidong, China","volume":"10","author":"Chen","year":"2003","journal-title":"J Med Screen"},{"key":"10.1016\/j.clinre.2023.102248_bib0060","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jceh.2014.03.047","article-title":"Tissue diagnosis of hepatocellular carcinoma","volume":"4","author":"Jain","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0061","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12072-010-9230-2","article-title":"Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B","volume":"5","author":"Long","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2023.102248_bib0062","first-page":"296","article-title":"Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas","volume":"9","author":"Long","year":"2010","journal-title":"HBPD INT"},{"key":"10.1016\/j.clinre.2023.102248_bib0063","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/modpathol.2015.162","article-title":"Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma","volume":"29","author":"Nguyen","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinre.2023.102248_bib0064","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0030-1247129","article-title":"Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis","volume":"30","author":"Roskams","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinre.2023.102248_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fmed.2017.00010","article-title":"Tissue biomarkers in hepatocellular tumors: which, when, and how","volume":"4","author":"Di Tommaso","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0066","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00534-010-0367-0","article-title":"The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma","volume":"18","author":"Shin","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.clinre.2023.102248_bib0067","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3346\/jkms.2005.20.5.829","article-title":"Expressions of HSP70 and HSP27 in hepatocellular carcinoma","volume":"20","author":"Joo","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinre.2023.102248_bib0068","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.21531","article-title":"Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis","volume":"45","author":"Di Tommaso","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2023.102248_bib0069","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/gutjnl-2011-301862","article-title":"Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma","volume":"61","author":"Tremosini","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2023.102248_bib0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jceh.2017.09.005","article-title":"Diagnostic value of glypican3, heat shock protein 70 and glutamine synthetase in hepatocellular carcinoma arising in cirrhotic and non-cirrhotic livers","volume":"8","author":"Uthamalingam","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0071","first-page":"2859","article-title":"Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity","volume":"62","author":"Moudi","year":"2018","journal-title":"Eur J Histochem"},{"key":"10.1016\/j.clinre.2023.102248_bib0072","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2147\/OTT.S127100","article-title":"Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition","volume":"10","author":"Xu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clinre.2023.102248_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.769233","article-title":"Prognostic influence of spontaneous tumor rupture in patients with hepatocellular carcinoma after hepatectomy: a meta-analysis of observational studies","volume":"8","author":"Xu","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.clinre.2023.102248_bib0074","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1072-7515(00)00700-6","article-title":"Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma","volume":"191","author":"Hanazaki","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clinre.2023.102248_bib0075","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/0016-5085(94)90024-8","article-title":"Overexpression of glutamine synthetase in human primary liver cancer","volume":"106","author":"Christa","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2023.102248_bib0076","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/hepr.13433","article-title":"Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition","volume":"50","author":"Liu","year":"2020","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.clinre.2023.102248_bib0077","first-page":"20722","article-title":"Glutamine synthetase predicts adjuvant TACE response in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0078","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1097\/CM9.0000000000002380","article-title":"Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy","volume":"136","author":"Shao","year":"2023","journal-title":"Chin Med J"},{"key":"10.1016\/j.clinre.2023.102248_bib0079","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.transproceed.2017.01.048","article-title":"Immunoexpression of heat shock protein 70, glypican 3, glutamine synthetase, and beta-catenin in hepatocellular carcinoma after liver transplantation: association between positive glypican 3 and beta-catenin with the presence of larger nodules","volume":"49","author":"Ataide","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2023.102248_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.07.002","article-title":"Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair","volume":"28","author":"Fu","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.clinre.2023.102248_bib0081","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15384047.2019.1665394","article-title":"Glutamine synthetase facilitates cancer cells to recover from irradiation-induced G2\/M arrest","volume":"21","author":"Peng","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clinre.2023.102248_bib0082","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1038\/emm.2017.174","article-title":"Glutamine synthetase mediates sorafenib sensitivity in beta-catenin-active hepatocellular carcinoma cells","volume":"50","author":"Sohn","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.clinre.2023.102248_bib0083","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-11-2322","article-title":"Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib","volume":"18","author":"Lachenmayer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0084","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.clinre.2023.102248_bib0085","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nature09144","article-title":"Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology","volume":"465","author":"Poliseno","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2023.102248_bib0086","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41392-021-00801-2","article-title":"An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity","volume":"6","author":"Wei","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.clinre.2023.102248_bib0087","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.14317","article-title":"Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma","volume":"79","author":"Montasser","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.clinre.2023.102248_bib0088","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/hep.28710","article-title":"Programmed death ligand 1 expression in hepatocellular carcinoma: relationship With clinical and pathological features","volume":"64","author":"Calderaro","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2023.102248_bib0089","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/1078-0432.CCR-09-1978","article-title":"Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation","volume":"16","author":"Dal Bello","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinre.2023.102248_bib0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2006.11.017","article-title":"R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells","volume":"46","author":"Behari","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2023.102248_bib0091","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/156800911797264725","article-title":"l-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of beta-catenin-mutated human hepatocellular carcinoma cells","volume":"11","author":"Tardito","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.clinre.2023.102248_bib0092","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/187152011796011019","article-title":"Points of therapeutic intervention along the Wnt signaling pathway in hepatocellular carcinoma","volume":"11","author":"Nambotin","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.clinre.2023.102248_bib0093","first-page":"132","article-title":"Glutamine synthetase limits beta-catenin-mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1","author":"Dai","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2023.102248_bib0094","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajpath.2019.02.002","article-title":"beta-catenin and yes-associated protein 1 cooperate in hepatoblastoma pathogenesis","volume":"189","author":"Min","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinre.2023.102248_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2023.102248_bib0096","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.clinre.2023.102248_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-Associated Macrophages in Tumor Immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinre.2023.102248_bib0098","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/febs.14295","article-title":"Metabolism and TAM functions-it takes two to tango","volume":"285","author":"Mazzone","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.clinre.2023.102248_bib0099","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.clinre.2023.102248_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13373","article-title":"Single-cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers","author":"Wei","year":"2023","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clinre.2023.102248_bib0101","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s42255-022-00598-6","article-title":"Author Correction: glutamine synthetase licenses APC\/C-mediated mitotic progression to drive cell growth","volume":"4","author":"Zhao","year":"2022","journal-title":"Nat Metab"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:00Z","timestamp":1761896100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740123001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2210740123001730"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102248","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamine synthetase and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102248"}}